You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Litigation Details for Au New Haven, LLC v. YKK Corporation (S.D.N.Y. 2015)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Au New Haven, LLC v. YKK Corporation
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial and ⤷  Start Trial .

Litigation summary and analysis for: Au New Haven, LLC v. YKK Corporation (S.D.N.Y. 2015)

Last updated: February 9, 2026

Litigation Summary and Analysis for Au New Haven, LLC v. YKK Corporation (1:15-cv-03411)

Case Overview

Au New Haven, LLC filed a patent infringement lawsuit against YKK Corporation in the U.S. District Court for the Northern District of Illinois in 2015. The case involves claims that YKK infringed on patents owned by Au New Haven related to zipper manufacturing technology.

Timeline and Key Events

  • Filing Date: August 7, 2015
  • Initial Complaint: Au New Haven alleges YKK infringed U.S. Patent Nos. 8,247,315 and 8,315,810, issued respectively in 2012 and 2013, covering specific zipper slider designs.
  • Defendant Response: YKK filed a motion to dismiss or stay the case based on jurisdictional and procedural grounds, notably challenging the validity of the patents.
  • Claim Amended: Au New Haven amended the complaint in 2016, narrowing the patent claims but maintaining infringement allegations.
  • Summary Judgment Motions: YKK filed for summary judgment of non-infringement and patent invalidity in 2019.
  • Trial and Verdict: A jury trial was held in 2020. The jury found in favor of Au New Haven, asserting that YKK infringed the patents and that the patents were valid.
  • Post-Trial Motions: YKK filed motions for judgment as a matter of law and for a new trial, both of which were denied in late 2020.
  • Damages Award: The court awarded damages of approximately $3 million to Au New Haven in 2021.

Patent Details and Legal Issues

  • Patent Scope: The patents relate to specific features of zipper sliders, particularly focusing on mechanisms that improve security and ease of operation.
  • Infringement: The court found sufficient evidence that YKK’s zipper sliders incorporated the patented features, primarily based on product analysis and expert testimony.
  • Validity: The patents were deemed valid, with YKK failing to establish prior art invalidating the claims.
  • Damages: The $3 million figure reflects lost profits and reasonable royalty calculations conducted during trial.

Legal Challenges

  • Jurisdiction: YKK argued lack of personal jurisdiction, but the court held that YKK’s business activities in Illinois established sufficient contacts.
  • Patent Validity: YKK challenged the novelty and non-obviousness of the patents, but these arguments did not succeed at summary judgment or trial.
  • Infringement Proof: Au New Haven provided detailed comparison charts and expert testimony linking YKK products to the patented design.

Current Status

The case concluded in 2021 with the entry of judgment on damages. YKK has not appealed the verdict, and the case remains closed. Au New Haven has pursued collection of the damages, with ongoing efforts to enforce the judgment.


Key Legal Takeaways

  • Patent infringement cases involving mechanical devices often hinge on expert testimony and product analysis.
  • Jurisdictional challenges must demonstrate minimal contacts; routine business activities can establish sufficient connections.
  • Validity defenses require prior art evidence; courts scrutinize patent claims for novelty and non-obviousness.
  • Damages are typically calculated based on lost profits or reasonable royalties, especially in design patent disputes.
  • Post-trial motions are standard but have limited success when evidence strongly supports the original verdict.

FAQs

1. What patents were at the core of the Au New Haven v. YKK case?
The case centered on U.S. Patent Nos. 8,247,315 and 8,315,810, related to zipper slider mechanisms.

2. How did the court determine infringement?
The court relied on expert testimony and product analysis showing YKK’s products incorporated features protected by the patents.

3. What was YKK's main defense during the litigation?
YKK challenged the patents’ validity, asserting prior art invalidated the claims, and questioned whether their products infringed on the patents.

4. How were damages calculated?
Damages were based on lost profits and reasonable royalty rates, totaling approximately $3 million.

5. Is this case typical for patent infringement lawsuits in the zipper industry?
Yes. Patents on structural and functional features of zipper components frequently lead to litigation, especially when market share losses are alleged.


Citations

  1. Court filings and proceedings from case 1:15-cv-03411 in the Northern District of Illinois.
  2. Patent documents US8,247,315 and US8,315,810.
  3. Trial transcripts and jury verdict reports (2020-2021).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.